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Summary 
The immunologic mechanism of protective immunity to  the  intracdlular  parasite  Listeria 
monocytogenes (Lm) is not well understood, however, antilisterial  immunity can be adoptively 
transferred with T lymphocytes from Lm-immune donors. The Lm-immune cells are believed 
to produce macrophage-activating lymphokines, which leads to the eventual macrophage-dependent 
eradication of the bacterium. Increasing evidence suggests that immunity to Lm resides exclusively 
within the CD8 + T cell subset.  It is possible that the Lm-immune CD8 + T cells function to 
release  sequestered  Lm from nonprofessional phagocytes to  awaiting activated macrophage 
populations. This study was conducted to determine iflisteriolysin O (LLO), which is an essential 
determinant of Lm pathogenicity, is also a target of the antilisterial  immune response. We have 
found that target calls infected with a LLO + Lm strain are lysed by Lm-immune cytotoxic cells, 
whereas  target  cells  infected with  a  LLO-  Lm mutant,  or  pulsed with  a  heat-killed Lm 
preparation, are not lysed by the Lm-immune effector cells. We have used a Bacillus subtilis (Bs) 
construct that expresses the LLO gene product and found that target cells infected with the 
LLO + Bs construct are lysed by antilisterial  cytotoxic cells. The antilisterial  cytotoxic response 
is targeted against LLO, in that we have also used a Bs construct that expresses the perfringolysin 
(PLO) gene product and found that target cells infected with the PLO + Bs are not lysed by 
antilisterial  cytotoxic effector cells. These data strongly suggest that LLO is a target antigen 
of antilisterial  immunity and may represent the dominant target during the expression of the 
immune response to Lm. 
L 
teria monocytogenes (Lm)  1 is  a  facultative  intracellular 
parasite that can grow intracytoplasmically within pa- 
renchymal cells as well as macrophages after escape from the 
phagolysosome (1-3). This escape has been directly associated 
with the production of listeriolysin  O  (LLO), a hemolysin 
produced  by allvindent strains of Lm (4). Our previous finding 
that a recombinant strain of Bacillus subtilis (Bs), which ex- 
presses the LLO gene of Lm, acquired the ability to escape 
from the phagolysosome and replicate  intracytoplasmically 
after phagocytosis by a macrophage-like cell line supports the 
role of LLO in Lm virulence (5). 
Immunity to Lm is T  ceU dependent with the ultimate 
destruction of the parasite contingent on the appearance of 
activated  macrophages (6,  7). Although CD4 +,  CD8-  T 
cells contribute to the development of antilisterial immunity, 
it has been demonstrated that the CD4-,  CD8 + subset  is 
the required effector T cell component for expression of high 
levels of adoptively transferred antilisterial  immunity (8, 9). 
Cells of this latter subset often express antigen-specific class 
I-restricted cytotoxicity, and this restriction has been reported 
for expression of antilisterial immunity (10). It also has been 
reported that cytotoxidty and immunity to Listeria can be 
expressed in a non-MHC-restricted fashion (11). In either case, 
the identity of the Listeria-derived  antigens that are targets 
of the protective antilisterial  response remains unknown. In 
this report we demonstrate that antilisterial  cytotoxic cells 
only recognize target cells that have been infected with bac- 
teria of the LLO § phenotype. 
1 Abbreviations used in this paper: BFA, brefddin  A;  BHI, brain  heart 
infusion; Bs, Bacillus subtilis; HKLM, heat-killed Listeria raonoo/togenes; 
IFIG, isoprow1  ~-D-thiogalactopyranoside;  Lm, Listeria  raonoo/togenes;  LLO, 
listeriolysin O; PLO, perfringolysin O. 
Materials and Methods 
Bacter/a.  Lm 10403 serotype 1 was originally obtained from 
the American  Type  Culture Collection (Rockville,  MD). Virulence 
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strain 10403 is ~4.5  x  10  ~ bacteria injected intravenously into 
BALB/c mice. Lm DP-L215 is a transposon-induced LID- mu- 
tant (12). Bs strain 980 (Bs980) has been transformed with the LID 
gene, and only produces LID in the presence of isopropyl B-D- 
thiogehctopyranofide  (IPTG; Sigma Chemical Co., St. Louis, MO) 
Bs strain 979 (Bs979) is the transformant control for Bs980. These 
strains have been described previously (5). Bs strain 1512 (Bs1512) 
has been transformed with the perfringolysin O (PLO) gene from 
Clostridium/x,  rj'r/agens, and Bs1512 only produces PLO in the pres- 
ence of  IFIG. Heat-killed  Lm (HKI.M) was Inepared  by incubating 
a brain heart infusion (BHI; Difr.o  Laboratories, Detroit, MI) broth 
culture of log-phase Lm 10403 at 60~  for 60 min. 
ltrl'G Induction of HemolTsin Expression by Bs980 and Bsi512. 
Streak plates of Bs980 and Bs1512 were prepared 24 h before IPTG 
exposure. A BHI broth suspension of the organism was prepared 
and diluted to an OD~ of 0.05 in 10 ml of BHI +  5 mM IFIG, 
and placed  in a shaking 37~  water bath. After 2 h (mid-log phase 
growth), the organisms were used in the cytotoxicity assay. Super- 
natant material was collected from the IFrG-induced cultures for 
verification  of LID or PLO production. Hemolytic activity of the 
supematants was determined by SRBC lysis. 
M/c~  6-wk-old female BALB/c mice were purchased from 
Bantin-Kingman (Fremont, CA). 
Immunization.  8-wk-old  BALB/c mice were immunized with 
,,o0.1 LDs0 of viable Lm injected in a 0.2-ml volume via the tail 
vein. 
Cell Culture  Spleen  cells from mice immunized 6 d previously 
wish Lm were stimulated in culture with 1.0 ~g/ml Con A (Sigma 
Chemical Co.) in R.PMI 1640 (Gibco Laboratories, Grand Island, 
NY)  supplemented with 5% FCS (Tissue Culture Biologicals, 
Tulare, CA). A total of 10  s lymphoid cells were cultured in 75- 
cm  2 flasks (Falcon Labware, Oxaard,  CA)  in  50-ml volumes. 
These spleen cells were cultured for 72 h and maintained at 37~ 
in humidified 7.5% CO2 and 92.5% air. 
Antibody Plus Complement Mediated Depletion of Splenic Lympho- 
cyte  Popu/ations.  COn A-stimulated immune spleen  cells were sus- 
pended  at  107  cells/mi in  RPMI  containing  anti-Thy-l.2 (hy- 
bridoma  30-H12), anti-CD4  (hybridoma GK1.5), or anti-CD8 
(hybridoma 19-178) at 4~  for 1 h with occasional mixing. The 
antibody-treated cell suspensions were pelleted and resuspended  in 
Low Tox-M rabbit complement (Accurate Chemical & Scientific 
Corp., Westbury, NY) diluted 1:12 in RPMI containing  0.3% BSA. 
The cells were incubated at 37~  for 1 h with occasional  mixing. 
The cell suspensions were pelleted, and viability was determined 
by nigrosine dye exclusion. The cell populations were analyzed  by 
flow cytometry to confirm efficiency  of specific subset depletion. 
Determination of lo81o Protection.  Recipient  mice were infused 
intravenously with 2-5  x  107 Lm-immune cells in a volume of 
0.2 ml. 1 d after adoptive transfer, groups of mice (four to five 
per group) were challenged with a 10 Ls0 dose of viable Lm 10403 
administered  intravenously.  The recipient spleens  were removed  48 h 
after the challenge and individually homogenized in 4.5 ml of 1% 
proteose-peptone in PBS. The homogenates were serially diluted, 
and plated onto BHI agar. Log10 protection was determined by 
subtracting the mean log~0 CFU/spleen of the test group from the 
mean log10 CFUApleen of the normal control group. 
Cytotoxicity Assay.  J774 macrophage like target cells (Amer- 
ican Type Culture Collection) were plated at 2  x  10  s cells/well 
(24-well plate; Costar, Cambridge, MA) in antibiotic-free DMEM 
(Gibco Laboratories)  supplemented with nonessential amino acids 
(Gibco Laboratories) and 5% FCS. 18 h later, the J774 monolayers 
were infected with either Lm 10403, Lm DP-L215, Bs980, Bs979, 
Bs2512, or pulsed  with HKLM. After 60 min, the monohyers were 
washed three times with prewarmed sterile PIGS, and after the last 
PBS wash, extracellular  bacterial replication was prevented by the 
addition  of 0.5  ml DMEM  containing  20  /~g gentamycin. If 
the J774 target cells were to be used in a chromium release assay, 
the J774  target  cells were hbeled  with 30/~Ci/wen S:Cr for 
2 h. The J774 target cells were washed three times with PBS to 
remove caress SICr, and 0.5 ml DMEM  +  5%  F'CS  +  gen- 
tamycin was added after the final wash. Effector cell populations 
were added in a 0.5-rnl volume 4 h after initiation of the infection 
to the S:Cr-hbeled or nonlabeled  J774 target cell monolayers.  The 
assay  was terminated 4 h after the addition of the effector  cell popu- 
lations. For determination  of specific StCr release, the 24-well 
plates were centrifuged, and 500/~1 of supernatant was removed 
for analysis.  The percentage of specific StCr release was calculated 
as (experimental  release -  background rehase)/(maximum release 
-  background release). Intracellular bacteria were recovered by 
lysing the J774 target cells with I ml sterile distilled water. 5 min 
later, dilutions of the bacterial suspensions were plated onto BHI 
agar plates. The plates were incubated overnight at 37~  and the 
number of CFU was determined. The percent reduction in Lm 
was determined by: viable Lm per well of target cells incubated 
with effector cells/viable Lm per well of target cells incubated in 
the absence of effector cells. 
Brefeldin A (BFA).  BFA was dissolved  in methanol, and added 
to the Lm-infected  J774 target cells at 0.5/~g/well 2 h after the initi- 
ation  of the  infection.  The  presence of BFA was  maintained 
throughout the remainder of the assay period. In several experi- 
ments,  BFA was removed by washing the infected J774 target 
monolayers three times with PBS before the addition of effector 
cell populations. BFA does not inhibit extracellular  or intracellular 
replication of Lm. 
Results  and  ~on 
In this investigation we used the J774 macrophage-like 
cell line infected with either Lm or hemolysin-producing 
constructs of Bs in an attempt to elucidate the role of LID 
in the immune response  to Lm. As reported previously (5), 
in the presence of IPTG, strain Bs980 is able to produce LID. 
Consequently, after phagocytosis by the J774 cell line, IPTG- 
induced Bs980 is able to escape the phagolysosome and repli- 
cate intracellularly. In this study we also used a Bs construct, 
strain Bs1512, which we observed to produce PLO in the 
presence of Itrl'G, and which was also able to replicate within 
the J774 macrophage-like cell line. These two recombinant 
strains provided an opportunity to determine ffLLO is a target 
of antilisterial cytotoxic cells. We have determined that the 
population of L/ster/a-immune spleen cells, which are obtained 
after stimulation in culture with the polyclonal T cell mitogen 
Con A, and which adoptively transfer enhanced levels of an- 
tilisterial immunity, also show an enhanced ability to lyse 
Lm-infected target cell populations. The J774 macrophage-like 
cell line has been used to describe various biological features 
of a Lm infection, and is used as the target cell population 
in this study (13). 
As presented in Table  1,  antilisterial cytotoxic cells (the 
cell population obtained after stimulation of L/ster/a-immune 
spleen cells in culture with Con A) lyse J774 targets infected 
with  viable  LiD-producing  Lm.  Antilisterial  cytotoxic 
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J774 target ceils  Effector ceil  Addition of  Percent decrease  Percent SlCr 
infected with*  population*  BFAS  of ListeriaM  release  I 
Lm 10403,  LLO +  Normal  -  26  22 
Lm immune  -  90  80 
Lm immune  +  2  NT 
Lm immune  +  -  >-  **  84  NT 
Lm DP-L215,  LLO-  Normal  -  22  4 
Lm immune  -  17  8 
HKLM  Normal  -  NT  2 
Lm immune  -  NT  12 
Lm 10403,  LLO +  Lm immune (CD8 +)**  -  94  NT 
Lm immune (CD4 +)  -  18  NT 
* Cultures of the J774 target cells were infected with Lm from an overnight broth suspension. For the LLO + wild-type strain, the multiplicity 
of infection (MOI) was 0.2-0.5.  For the LLO- DP-L215 strain, the/VIOl was 10-20. The HKLM was added at ~50 organisms~J774 cell. 
* Con A-stimulated normal spleen cells (normal) and Con A-stimulated immune spleen cells (Lm immune) were added to the J774 monolayers 4 h 
after initiation of Lm infection. These effector cell populations were added at an E/T cell ratio of 5:1 in a 0.5-ml volume. 
$ BFA was added at 0.5/~g/well to the J774 monolayers 2 h after the initiation of the Lm infection. 
H  The assay was terminated 4 h after the addition of effector cell populations. At the final time point, the number of L/ster/a/well was determined 
as described in Materials and Methods. The data are presented as percent reduction in viable Listeria/well of target cells incubated with effector cells 
compared with L/ster/a/wdl of target cells incubated  without effector  cells. Data are representative  of at least four independent  experiments.  NT, not tested. 
'I Target cells were cultured and infected as described above and in Materials and Methods. The percentage of specific slCr release was calcuhted 
as (experimental release-background  release)/(maximum release-background  release). 
** BFA was removed by washing at the time the effector cell populations were added. 
** Antibody plus complement-mediated depletion was performed as described in Materials and Methods. Effector cells were added at an E/T cell 
ratio of 5:1. 
cell-mediated lysis was not seen after J774 target cell phago- 
cytosis  of  either  the  LLO-  DP-L215  strain  of  Lm  or 
HKLM.  Data in Table 1 also demonstrate that antilisterial 
cytotoxidty is a property of the CD4-, CD8 + T  cell subset. 
Target cell development is dependent on an intraceUular pro- 
cessing event that is inhibited in the presence of BFA,  and 
this BFA-mediated inhibition of target cell lysis is reversible. 
BFA  has  been  shown  to  inhibit  endogenous  pathway- 
dependent transport of antigen and accessory cell molecule 
to the cell surface (14). Other studies also have shown that 
L/ster/a-immune CD4-,  CD8 +  T  cell-dependent recogni- 
tion of target cells requires intracellular growth of LM, which 
is only seen with strains producing LLO (15). However, there 
are  at  least  two  reports  indicating  that  CD4-,  CD8 +  T 
cell-mediated cytotoxicity occurs after phagocytosis of HKLM 
(11,  16), a finding that could not be duplicated in this study. 
The results in Table 1 indicate that  antilisterial cytotox- 
icity is observed only in target cells in which LLO produc- 
tion allows the intracellular replication of Lm, however, it 
is not clear if LLO is a target of the cytotoxic response. This 
possibility was addressed in a series of experiments in which 
the J774 cell line was infected with the various Bs constructs 
producing LLO (Bs980) or the heterologous hemolysin, PLO 
(Bs1512).  The data in Table 2 show that J774 cells infected 
with IFIG-induced strain Bs980 are recognized and lysed by 
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antilisterial cytotoxic cells. J774 cells infected with Bs980 in 
the absence of IFIG (and thus in the absence of LLO) are 
not targets for lysis by antilisterial cytotoxic cells. In addi- 
tion, J774 cells infected with IFIG-induced Bs1512 (and thus 
PLO +)  are  not  lysed  by  antilisterial  cytotoxic cells,  even 
though the Bs1512 strain produces PLO and replicates freely 
within the cytoplasm of the J774 cell. Therefore, the stimulus 
provided solely by the presence of Bs within the cytoplasm 
of the host cell does not render such cells susceptible to lysis 
by the antilisterial cytotoxic cell populations used in these 
assays. 
Previous reports have shown that LLO is a critical viru- 
lence factor and that cells of the CD4 +, CD8-  T  cell subset 
are produced during an immune response to Lm that recog- 
nize epitopes of LLO (17, 18). However, immunization with 
isolated LLO or immunogenic peptides does not produce im- 
munity to subsequent infection with Lm, although a CD4 +, 
CD8-  T  cell response can be readily measured  (18).  The 
lack of immunity seen in LLO-immunized animals may be 
related to the requirement of CD4-,  CD8 + T  cells for full 
expression of antilisterial immunity (9,  19).  Thus,  ff LLO 
is an important target of the antilisterial immune response, 
then immunization protocols ensuring a CD4-,  CD8 + T 
cell response to LLO epitopes are required to identify the im- 
portance of this component in a primary antilisterial response. Table  2.  Listeria-irnmune Cytotoxic Cells Recognize Listeriolysin 
Target cells  Hemolysin  Effector cell  Percent decrease 
infected with"  production#  populations  of bacteria# 
Lm  10403  LLO  Normal  18 
Lm immune  91 
Bs979  -  Normal  28 
Lm immune  34 
Bs979 + IPTG  -  Normal  17 
Lm immune  25 
Bs980  -  Normal  19 
Lm immune  16 
Bs980 + IPTG  LLO  Normal  22 
Lm immune  87 
Bs1512 + IPTG  PLO  Lm immune  5 
" The J774 cells were infected with  the various strains of bacteria as 
described in Materials and Methods. 
* Of the various strains of bacteria used to infect the J774 target cells, 
some constitutively  produce LLO, while others can be induced to produce 
LLO or PLO after IPTG exposure. 
S Con A-stimuhted  normal spleen cells (normal) and Con A-stimulated 
immune spleen cells (Lm immune) were added to the J774 monolayers 
4 h after initiation of infection. These effector cell populations were ad- 
ded at an E/T cell ratio of 5:1 in a 0.5-ml volume. 
II The assay was terminated 4 h after the addition of effector cell popu- 
lations. At the final time point, the number of bacteria/well was deter- 
mined as described in Materials and Methods. The results are represented 
as percent reduction in viable bacteria/well of target cells incubated with 
effector  cells compared with bacteria/well of target cells incubated without 
effector cells. Data are representative of at least four independent ex- 
periments. 
In  a recent report,  it was  shown  that  H-2  d Listeria  im- 
mune cells lysed H-2  a target  cells pulsed with  a  synthetic 
peptide that corresponds to the 91-99 region of the LLO pro- 
tein (20). This nanomer fulfills the binding motif require- 
ments for interaction with the H-2K  a molecule. Although 
additional  synthetic  LLO  molecule  nanomers  that  fulfill 
H-2K  d  binding  motif  constraints  were  tested,  only  the 
91-99 region was found to sensitize target cells for lysis. The 
in vivo activity of the antilisterial cytotoxic cell line popula- 
tion used for this study was not reported. Therefore, the im- 
portance of the 91-99 region of LLO as a target by cells capable 
of adoptively transfm,  ing antilisterial immunity is not known. 
Considering the intracellular biology of Lm, it is likely that 
LLO is a critical target of a protective antilisterial response. 
LLO is apparently required for the initial escape of the or- 
ganism from the phagocytic vesicle (13, 21).  Escape to the 
cytoplasm is an early event in the parasitic life cycle of Lm. 
Thus, the production of LLO within the phagolysosome may 
lead to peptide association with MHC molecules, transport 
to the target cell surface,  and recognition by Lm-immune 
T  cells. This would be analogous to the early proteins pro- 
duced in virally infected cells that are also the targets of pro- 
tective immune responses (22, 23). It is possible to consider 
that although many listerial antigens may be produced during 
the intracellular growth of this microbe, only a limited number 
of  antigens  are  crucial  for  immunologic  recognition  by 
L/ster/a-immune cytotoxic cells. As a corollary, it is possible 
that recognition of a L/ster/a-infected cell by CD4-,  CD8 § 
L/ster/a-specific T  cells is limited to epitopes of the listeri- 
olysin molecule. The data provided here demonstrate that LLO 
is one, if not the major, antigen associated with the immune 
T  cell response in antilisterial  immunity. 
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